scholarly journals The effects of lifelong cognitive lifestyle on executive function in older people with Parkinson's disease

2017 ◽  
Vol 32 (12) ◽  
pp. e157-e165 ◽  
Author(s):  
John V. Hindle ◽  
Pamela A. Martin-Forbes ◽  
Anthony Martyr ◽  
Alexandra J.M. Bastable ◽  
Kirstie L. Pye ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Executive Function ◽  
Older People ◽  
Cognitive Lifestyle

O3-06-08: The therapeutic effect of donepezil on attention and executive function in patients with Parkinson's disease dementia (PDD)

2008 ◽  
Vol 4 ◽  
pp. T173-T173
Author(s):  
Jina E. Swartz ◽  
Margaret L. Moline ◽  
Julian Gray ◽  
Gail Thomas ◽  
Mark Harre ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Executive Function ◽  
Therapeutic Effect ◽  
Parkinson’S Disease Dementia

Alertness as assessed by clinical testing and alpha reactivity does not correlate with executive function decline in Parkinson's disease (PD)

2016 ◽  
Vol 22 ◽  
pp. e143
Author(s):  
Rolf Sturzenegger ◽  
Antonia Meyer ◽  
Menorca Chaturvedi ◽  
Vitalii Cozac ◽  
Florian Hatz ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Executive Function ◽  
Clinical Testing

Sleep Correlates of Trait Executive Function and Memory in Parkinson's Disease

2015 ◽  
Vol 5 (1) ◽  
pp. 49-54 ◽  
Author(s):  
Michael K. Scullin ◽  
Jacqueline A. Fairley ◽  
Lynn Marie Trotti ◽  
Felicia C. Goldstein ◽  
Stewart A. Factor ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Executive Function

Executive function and dopamine response in Parkinson's disease freezing of gait

2021 ◽  
Author(s):  
Travis H. Turner ◽  
Federico Rodriguez-Porcel ◽  
Philip Lee ◽  
Katherine Teague ◽  
Lisa Heidelberg ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Executive Function ◽  
Freezing Of Gait

Parkinsonism, Parkinson’s disease, and related conditions

2017 ◽  
pp. 897-906
Author(s):  
John V. Hindle ◽  
Sion Jones ◽  
Glesni Davies
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Older People ◽  
Lewy Bodies ◽  
Cell Loss ◽  
Brain Regions ◽  
Motor Symptoms ◽  
Advanced Care Planning ◽  
Non Motor Symptoms

Parkinson’s disease (PD) is a progressive neurodegenerative condition characterized clinically by fatiguable bradykinesia, rigidity and tremor and pathologically by deposition of Lewy bodies and cell loss in the substantia nigra and other brain regions. Parkinsonism is the term used to describe the clinical features of conditions resembling PD. Their management requires specialist assessment and a multidisciplinary approach. Levodopa remains the mainstay of treatment for PD. Although other treatments are used, older people are more sensitive to their side effects. Non-motor symptoms, particularly neuropsychiatric problems, significantly impact quality of life and need special consideration in older people. Towards the later stage of the disease, management can be complex, and should involve advanced care planning.

Sign in / Sign up

Export Citation Format

Share Document